Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...

Biomarker-activated cancer drug-candidate LP-184 demonstrates encouraging efficacy signals in DNA damage repair deficient ...

Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive ...

The MarketWatch News Department was not involved in the creation of this content. Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker ...

Please provide your email address to receive an email when new articles are posted on . Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers ...

One of the most important reasons for the recent improvements in lung cancer treatments is biomarker testing — testing to determine the exact kind of cancer a patient has, in order to enable the most ...

Lung cancer remains the most frequently diagnosed malignancy and the leading cause of cancer tumour-related mortality ...

Lung Cancer Diagnostics Market OverviewThe global lung cancer diagnostics market is undergoing significant expansion as healthcare systems, technology developers, and research institutions intensify ...

The global oncology biomarker market size is calculated at USD 38.62 billion in 2025 and is expected to reach around USD ...

In a unified push against one of the nation’s deadliest diseases, the country’s leading lung cancer experts, patient advocates, and policymakers have jointly released the Philippine Declaration on ...

For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and ...

Campaign aims to improve lung cancer survival through early detection, education and widespread access to biomarker testing. CHICAGO, Aug. 20, 2025 /PRNewswire/ -- For people with lung cancer, ...